Genetics, Genomics & Molecular Diagnostics News

Backed by €15 million in EU funding, the Ubiquitous Pharmacogenomics Consortium seeks to implement preemptive testing at seven healthcare systems by 2020.

In addition to variant detection technology, Omicia also gets technologies like data compression, which will aid diagnostics development and data storage. 

Through the deal, Ginkgo has picked up Gen9's manufacturing platform and suite of proprietary technologies, software, and informatics tools for DNA synthesis and assembly.

The researchers used both targeted and exome sequencing to genetically diagnose patients.

The grants are provided through the NSF's Early Concept Grants for Exploratory Research program in partnership with the National Institute of Food and Agriculture.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.

Genotoxicity workflows performed manually are subject to workflow bottlenecks, where the throughput is inherently limited, and active time spent performing the tests reduces the lab’s overall efficiency. Additionally, variability associated with operator technique and laboratory conditions could lead to a loss in precision, or worse, systematic errors that can skew results. This article demonstrates automated imaging as it pertains to the comet and gamma-H2AX assays in order to simplify genotoxicity assay workflows and provide robust results.

Stringent guidelines of quality assurance and control (QA/QC) serve as the foundation for dependable and reproducible results in any analytical endeavor. Here we highlight step-by-step, the measures implemented by Myriad RBM that take Luminex xMAP technology to a high level of reproducibility and ruggedness. The Myriad RBM platform combines the sensitivity and dynamic range of microsphere-based immuno-multiplexing with the precision and dependability of automated liquid handling.

Single cell analysis has become increasingly important in translational research allowing scientist to study cell-to-cell variations within a cell population. However, the current flow cytometry protocols are limited to 16-20 protein biomarkers and samples are stable for only 1-5 days. In this White Paper we present an overview on assays, instrumentation and applications of the high parameter ChipCytometry platform and the ability to store clinical samples for a period of 24 months at full biomarker integrity.